Pacira completes MyoScience takeover

|About: Pacira BioSciences, Inc. (PCRX)|By:, SA News Editor

Pacira BioSciences (NASDAQ:PCRX) has finalized its merger with privately held MyoScience.

Under the terms of the deal, Pacira paid $120M upfront and will pay up to an additional $100M in milestones.

The company expects the transaction to be accretive to net income in H2 2020 and increasingly accretive thereafter.

Subscribe for full text news in your inbox